Analyst Favorites
Highly-rated stocks with high upside.
Filters: Rating ≥ 75; Target Upside > 15%
Total Market Cap: $25T
Rank | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (751 stocks) | +36.03% | +42.13% | 26.85 | 21.01 | 0.44 | 2.57% | 0.75% | +25.70% | 1.30 | |||||||
1 | ITRM | Iterum Therapeutics Plc | $0.18 | $8.06M | +5013.64% | 87 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | $9 | -61.63% | 1.11 |
2 | CRIS | Curis Inc | $0.42 | $17M | +3224.63% | 81 | Biotechnology | Healthcare | -31.57% | N/A | N/A | N/A | N/A | N/A | $14 | -69.57% | 1.20 |
3 | SLXN | Silexion Therapeutics Corp | $3.13 | $1.30M | +1816.93% | 87 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | $60 | 0.00% | 2.18 |
4 | ICCM | Icecure Medical Ltd | $2.39 | $6.18M | +1761.92% | 87 | Medical Devices | Healthcare | -5.73% | N/A | N/A | N/A | N/A | N/A | $45 | -42.88% | 0.99 |
5 | KAPA | Kairos Pharma Ltd | $0.44 | $9.21M | +1718.18% | 83 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | -40.87% | N/A | $8 | 0.00% | 0.60 |
6 | MDCX | MDCorp | $0.34 | $12M | +1579.01% | 83 | Drug Manufacturers - General | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | $5.67 | +47.73% | 0.99 |
7 | FEMY | Femasys Inc | $4.18 | $14M | +1415.07% | 91 | Medical Instruments & Supplies | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | $63 | 0.00% | 1.12 |
8 | SNTI | Senti Biosciences Inc | $0.96 | $30M | +1071.63% | 81 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | $11 | -60.54% | 1.47 |
9 | AMOD | Alpha Modus Holdings Inc - Class A | $0.13 | $11M | +1026.13% | 100 | Software - Application | Technology | N/A | N/A | N/A | N/A | -39.49% | N/A | $1.50 | 0.00% | 0.97 |
10 | MTVA | MetaVia Inc | $1.74 | $10M | +1010.92% | 87 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | $19 | -82.43% | N/A |
11 | ACXP | Acurx Pharmaceuticals Inc | $1.57 | $5.42M | +982.80% | 83 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | $17 | 0.00% | 1.03 |
12 | WKSP | Worksport Ltd | $0.63 | $7.54M | +978.27% | 87 | Auto Parts | Consumer Cyclical | -0.18% | N/A | N/A | N/A | N/A | N/A | $6.75 | -64.93% | 1.49 |
13 | ALGS | Aligos Therapeutics Inc | $5.28 | $32M | +966.10% | 78 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | $56 | -63.18% | 2.10 |
14 | RANI | Rani Therapeutics Holdings Inc Class A | $0.76 | $141M | +886.71% | 81 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | -12.14% | N/A | $7.50 | 0.00% | 2.24 |
15 | OCGN | Ocugen Inc | $1.21 | $403M | +844.63% | 78 | Biotechnology | Healthcare | +8.79% | N/A | 13.07 | N/A | -14.80% | N/A | $11 | -27.71% | 1.76 |
16 | PSQH | PSQ Holdings Inc - Class A | $0.48 | $26M | +838.87% | 87 | Software - Application | Technology | N/A | N/A | N/A | N/A | -67.17% | N/A | $4.50 | 0.00% | 1.92 |
17 | NXTC | Nextcure Inc | $2.08 | $8.04M | +831.57% | 83 | Biotechnology | Healthcare | -6.00% | N/A | N/A | N/A | N/A | N/A | $19 | -53.76% | 0.57 |
18 | ATOS | Atossa Therapeutics Inc | $2.46 | $38M | +824.80% | 83 | Biotechnology | Healthcare | +3.17% | N/A | 7.04 | N/A | -88.14% | N/A | $23 | -48.71% | 1.13 |
19 | LGVN | Longeveron Inc - Class A | $0.78 | $19M | +813.62% | 87 | Biotechnology | Healthcare | -21.63% | N/A | N/A | N/A | -97.54% | N/A | $7.15 | -59.61% | 1.21 |
20 | DWTX | Virios Therapeutics Inc | $1.54 | $50M | +809.09% | 87 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | -31.19% | N/A | $14 | -59.86% | 0.88 |
21 | CMMB | Chemomab Therapeutics Ltd | $1.67 | $13M | +798.20% | 87 | Biotechnology | Healthcare | N/A | N/A | 12.94 | N/A | N/A | N/A | $15 | -54.77% | 1.03 |
22 | IMNN | Imunon Inc | $2.02 | $7.77M | +741.58% | 81 | Biotechnology | Healthcare | -46.50% | N/A | 16.78 | 5.03 | N/A | N/A | $17 | -62.60% | N/A |
23 | OGI | OrganiGram Holdings Inc | $1.06 | $139M | +730.19% | 81 | Drug Manufacturers - Specialty & Generic | Healthcare | -44.61% | N/A | 44.84 | N/A | -10.84% | N/A | $8.80 | -39.01% | 1.26 |
24 | TOVX | Theriva Biologics Inc | $0.30 | $11M | +722.91% | 87 | Biotechnology | Healthcare | -21.74% | N/A | N/A | N/A | N/A | N/A | $2.50 | -71.52% | N/A |
25 | STEX | Streamex Corp | $0.97 | $44M | +722.88% | 100 | Capital Markets | Financial Services | -42.88% | N/A | N/A | N/A | -18.09% | N/A | $8 | -52.40% | 1.96 |
26 | MBRX | Moleculin Biotech Inc | $2.64 | $13M | +695.45% | 83 | Biotechnology | Healthcare | -27.22% | N/A | N/A | N/A | N/A | N/A | $21 | -71.76% | 1.64 |
27 | SCYX | Scynexis Inc | $4.23 | $32M | +693.14% | 83 | Drug Manufacturers - Specialty & Generic | Healthcare | -31.46% | N/A | 3.72 | N/A | -16.41% | N/A | $34 | -41.93% | 0.96 |
28 | TRNR | Interactive Strength Inc | $0.58 | $1.27M | +680.44% | 100 | Personal Services | Consumer Cyclical | N/A | N/A | N/A | N/A | N/A | N/A | $4.50 | 0.00% | N/A |
29 | ACRV | Acrivon Therapeutics Inc | $1.48 | $54M | +677.03% | 84 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | $12 | 0.00% | 1.80 |
30 | CRBU | Caribou Biosciences Inc | $1.60 | $174M | +652.35% | 78 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | -58.82% | N/A | $12 | 0.00% | 1.89 |
31 | HRTX | Heron Therapeutics Inc | $0.40 | $78M | +649.81% | 83 | Biotechnology | Healthcare | N/A | N/A | 46.95 | N/A | -26.93% | N/A | $3 | -52.04% | 1.27 |
32 | MNOV | Medicinova Inc | $1.23 | $63M | +631.71% | 83 | Biotechnology | Healthcare | -1.18% | N/A | 8.53 | N/A | -15.21% | N/A | $9 | -21.89% | 0.47 |
33 | PAVM | PAVmed Inc | $5 | $31M | +620.00% | 87 | Medical Devices | Healthcare | N/A | 0.50 | N/A | N/A | -20.15% | N/A | $36 | -71.42% | 1.07 |
34 | PSTV | Plus Therapeutics Inc | $5.01 | $37M | +618.56% | 81 | Biotechnology | Healthcare | -25.42% | N/A | 0.97 | 2.45 | -58.73% | N/A | $36 | -65.81% | N/A |
35 | QNRX | Quoin Pharmaceuticals Ltd | $4.20 | $9.92M | +608.33% | 83 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | $30 | -85.52% | N/A |
36 | CRDL | Cardiol Therapeutics Inc - Class A | $1.03 | $114M | +600.97% | 85 | Drug Manufacturers - Specialty & Generic | Healthcare | -10.43% | N/A | N/A | N/A | -15.37% | N/A | $7.22 | -16.93% | 1.32 |
37 | ANVS | Annovis Bio Inc | $1.79 | $57M | +600.28% | 87 | Biotechnology | Healthcare | +6.84% | N/A | N/A | N/A | -46.37% | N/A | $13 | -54.23% | 1.63 |
38 | NSRX | Nasus Pharma Ltd | $2.88 | $27M | +582.99% | 100 | Drug Manufacturers - General | Healthcare | N/A | N/A | N/A | N/A | -18.05% | N/A | $20 | 0.00% | 0.83 |
39 | TARA | Protara Therapeutics Inc | $3.90 | $208M | +581.28% | 81 | Biotechnology | Healthcare | -19.06% | N/A | N/A | N/A | -30.29% | N/A | $27 | -17.78% | 1.14 |
40 | UPB | Upstream Bio Inc | $6.10 | $359M | +527.05% | 78 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | -39.09% | N/A | $38 | 0.00% | 1.14 |
41 | APRE | Aprea Therapeutics Inc | $0.69 | $9.05M | +526.73% | 83 | Biotechnology | Healthcare | -49.70% | N/A | N/A | N/A | N/A | N/A | $4.30 | -63.14% | 0.87 |
42 | ONCY | Oncolytics Biotech Inc | $0.80 | $93M | +522.54% | 83 | Biotechnology | Healthcare | N/A | N/A | 45.45 | N/A | -21.65% | N/A | $5 | -22.70% | 0.87 |
43 | PRQR | ProQR Therapeutics N.V | $1.44 | $149M | +516.67% | 78 | Biotechnology | Healthcare | -13.05% | N/A | N/A | N/A | -38.61% | N/A | $8.88 | -27.98% | 1.27 |
44 | CTOR | Citius Oncology Inc | $0.66 | $64M | +502.41% | 100 | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 35.59 | N/A | -18.39% | N/A | $4 | 0.00% | N/A |
45 | OKYO | OKYO Pharma Ltd - New | $1.52 | $56M | +492.11% | 81 | Biotechnology | Healthcare | +375.62% | N/A | N/A | N/A | -13.06% | N/A | $9 | 0.00% | 0.80 |
46 | GNLX | Genelux Corp | $2.96 | $128M | +491.22% | 79 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | -21.74% | N/A | $18 | 0.00% | 1.46 |
47 | NAKA | Nakamoto Inc | $4.32 | $70M | +478.70% | 83 | Capital Markets | Financial Services | N/A | N/A | N/A | N/A | -65.26% | N/A | $25 | 0.00% | 2.57 |
48 | UNCY | Unicycive Therapeutics Inc | $7.25 | $194M | +469.66% | 80 | Biotechnology | Healthcare | N/A | N/A | 3.45 | N/A | -15.23% | N/A | $41 | 0.00% | 0.90 |
49 | PALI | Palisade Bio Inc | $1.71 | $281M | +467.84% | 82 | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | -4.41% | N/A | $9.71 | -77.79% | N/A |
50 | INMB | INmune Bio Inc | $1.24 | $32M | +464.52% | 81 | Biotechnology | Healthcare | +7.56% | N/A | N/A | N/A | -62.80% | N/A | $7 | -41.84% | 1.79 |